 | • レポートコード：QYR2104Z3240 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、93ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品、ヘルスケア |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、がん体外診断のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（機器、試薬、キット）、用途別市場規模（研究所、病院、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・がん体外診断の市場動向 ・企業の競争状況、市場シェア ・がん体外診断の種類別市場規模（機器、試薬、キット） ・がん体外診断の用途別市場規模（研究所、病院、その他） ・がん体外診断の北米市場規模2016-2027（アメリカ、カナダ） ・がん体外診断のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・がん体外診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・がん体外診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・がん体外診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（MDx Health Quest Diagnostics、R-Biopharm AG、Signature Diagnostics、Siemens Healthcare、Randox Laboratories、Epigenomics AG、Beckman Coulter、Abbott Laboratories） ・結論 |
In-vitro cancer diagnostics is a technique in which the reagents and medical devices are employed to examine specimens such as body fluids, tissues, stool, urine, and blood.
Market Analysis and Insights: Global In-Vitro Cancer Diagnostics Market
The global In-Vitro Cancer Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global In-Vitro Cancer Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global In-Vitro Cancer Diagnostics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global In-Vitro Cancer Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global In-Vitro Cancer Diagnostics market.
Global In-Vitro Cancer Diagnostics Scope and Market Size
In-Vitro Cancer Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global In-Vitro Cancer Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Instruments
Reagents and Kits
Segment by Application
Laboratories
Hospitals
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
MDx Health Quest Diagnostics
R-Biopharm AG
Signature Diagnostics
Siemens Healthcare
Randox Laboratories
Epigenomics AG
Beckman Coulter
Abbott Laboratories
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In-Vitro Cancer Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Instruments
1.2.3 Reagents and Kits
1.3 Market by Application
1.3.1 Global In-Vitro Cancer Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Laboratories
1.3.3 Hospitals
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global In-Vitro Cancer Diagnostics Market Perspective (2016-2027)
2.2 In-Vitro Cancer Diagnostics Growth Trends by Regions
2.2.1 In-Vitro Cancer Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 In-Vitro Cancer Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 In-Vitro Cancer Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 In-Vitro Cancer Diagnostics Industry Dynamic
2.3.1 In-Vitro Cancer Diagnostics Market Trends
2.3.2 In-Vitro Cancer Diagnostics Market Drivers
2.3.3 In-Vitro Cancer Diagnostics Market Challenges
2.3.4 In-Vitro Cancer Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In-Vitro Cancer Diagnostics Players by Revenue
3.1.1 Global Top In-Vitro Cancer Diagnostics Players by Revenue (2016-2021)
3.1.2 Global In-Vitro Cancer Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global In-Vitro Cancer Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by In-Vitro Cancer Diagnostics Revenue
3.4 Global In-Vitro Cancer Diagnostics Market Concentration Ratio
3.4.1 Global In-Vitro Cancer Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In-Vitro Cancer Diagnostics Revenue in 2020
3.5 In-Vitro Cancer Diagnostics Key Players Head office and Area Served
3.6 Key Players In-Vitro Cancer Diagnostics Product Solution and Service
3.7 Date of Enter into In-Vitro Cancer Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 In-Vitro Cancer Diagnostics Breakdown Data by Type
4.1 Global In-Vitro Cancer Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global In-Vitro Cancer Diagnostics Forecasted Market Size by Type (2022-2027)
5 In-Vitro Cancer Diagnostics Breakdown Data by Application
5.1 Global In-Vitro Cancer Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global In-Vitro Cancer Diagnostics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America In-Vitro Cancer Diagnostics Market Size (2016-2027)
6.2 North America In-Vitro Cancer Diagnostics Market Size by Type
6.2.1 North America In-Vitro Cancer Diagnostics Market Size by Type (2016-2021)
6.2.2 North America In-Vitro Cancer Diagnostics Market Size by Type (2022-2027)
6.2.3 North America In-Vitro Cancer Diagnostics Market Size by Type (2016-2027)
6.3 North America In-Vitro Cancer Diagnostics Market Size by Application
6.3.1 North America In-Vitro Cancer Diagnostics Market Size by Application (2016-2021)
6.3.2 North America In-Vitro Cancer Diagnostics Market Size by Application (2022-2027)
6.3.3 North America In-Vitro Cancer Diagnostics Market Size by Application (2016-2027)
6.4 North America In-Vitro Cancer Diagnostics Market Size by Country
6.4.1 North America In-Vitro Cancer Diagnostics Market Size by Country (2016-2021)
6.4.2 North America In-Vitro Cancer Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe In-Vitro Cancer Diagnostics Market Size (2016-2027)
7.2 Europe In-Vitro Cancer Diagnostics Market Size by Type
7.2.1 Europe In-Vitro Cancer Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe In-Vitro Cancer Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe In-Vitro Cancer Diagnostics Market Size by Type (2016-2027)
7.3 Europe In-Vitro Cancer Diagnostics Market Size by Application
7.3.1 Europe In-Vitro Cancer Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe In-Vitro Cancer Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe In-Vitro Cancer Diagnostics Market Size by Application (2016-2027)
7.4 Europe In-Vitro Cancer Diagnostics Market Size by Country
7.4.1 Europe In-Vitro Cancer Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe In-Vitro Cancer Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific In-Vitro Cancer Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Type
8.2.1 Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Application
8.3.1 Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Region
8.4.1 Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America In-Vitro Cancer Diagnostics Market Size (2016-2027)
9.2 Latin America In-Vitro Cancer Diagnostics Market Size by Type
9.2.1 Latin America In-Vitro Cancer Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America In-Vitro Cancer Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America In-Vitro Cancer Diagnostics Market Size by Type (2016-2027)
9.3 Latin America In-Vitro Cancer Diagnostics Market Size by Application
9.3.1 Latin America In-Vitro Cancer Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America In-Vitro Cancer Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America In-Vitro Cancer Diagnostics Market Size by Application (2016-2027)
9.4 Latin America In-Vitro Cancer Diagnostics Market Size by Country
9.4.1 Latin America In-Vitro Cancer Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America In-Vitro Cancer Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In-Vitro Cancer Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Type
10.2.1 Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Application
10.3.1 Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Country
10.4.1 Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 MDx Health Quest Diagnostics
11.1.1 MDx Health Quest Diagnostics Company Details
11.1.2 MDx Health Quest Diagnostics Business Overview
11.1.3 MDx Health Quest Diagnostics In-Vitro Cancer Diagnostics Introduction
11.1.4 MDx Health Quest Diagnostics Revenue in In-Vitro Cancer Diagnostics Business (2016-2021)
11.1.5 MDx Health Quest Diagnostics Recent Development
11.2 R-Biopharm AG
11.2.1 R-Biopharm AG Company Details
11.2.2 R-Biopharm AG Business Overview
11.2.3 R-Biopharm AG In-Vitro Cancer Diagnostics Introduction
11.2.4 R-Biopharm AG Revenue in In-Vitro Cancer Diagnostics Business (2016-2021)
11.2.5 R-Biopharm AG Recent Development
11.3 Signature Diagnostics
11.3.1 Signature Diagnostics Company Details
11.3.2 Signature Diagnostics Business Overview
11.3.3 Signature Diagnostics In-Vitro Cancer Diagnostics Introduction
11.3.4 Signature Diagnostics Revenue in In-Vitro Cancer Diagnostics Business (2016-2021)
11.3.5 Signature Diagnostics Recent Development
11.4 Siemens Healthcare
11.4.1 Siemens Healthcare Company Details
11.4.2 Siemens Healthcare Business Overview
11.4.3 Siemens Healthcare In-Vitro Cancer Diagnostics Introduction
11.4.4 Siemens Healthcare Revenue in In-Vitro Cancer Diagnostics Business (2016-2021)
11.4.5 Siemens Healthcare Recent Development
11.5 Randox Laboratories
11.5.1 Randox Laboratories Company Details
11.5.2 Randox Laboratories Business Overview
11.5.3 Randox Laboratories In-Vitro Cancer Diagnostics Introduction
11.5.4 Randox Laboratories Revenue in In-Vitro Cancer Diagnostics Business (2016-2021)
11.5.5 Randox Laboratories Recent Development
11.6 Epigenomics AG
11.6.1 Epigenomics AG Company Details
11.6.2 Epigenomics AG Business Overview
11.6.3 Epigenomics AG In-Vitro Cancer Diagnostics Introduction
11.6.4 Epigenomics AG Revenue in In-Vitro Cancer Diagnostics Business (2016-2021)
11.6.5 Epigenomics AG Recent Development
11.7 Beckman Coulter
11.7.1 Beckman Coulter Company Details
11.7.2 Beckman Coulter Business Overview
11.7.3 Beckman Coulter In-Vitro Cancer Diagnostics Introduction
11.7.4 Beckman Coulter Revenue in In-Vitro Cancer Diagnostics Business (2016-2021)
11.7.5 Beckman Coulter Recent Development
11.8 Abbott Laboratories
11.8.1 Abbott Laboratories Company Details
11.8.2 Abbott Laboratories Business Overview
11.8.3 Abbott Laboratories In-Vitro Cancer Diagnostics Introduction
11.8.4 Abbott Laboratories Revenue in In-Vitro Cancer Diagnostics Business (2016-2021)
11.8.5 Abbott Laboratories Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global In-Vitro Cancer Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Instruments
Table 3. Key Players of Reagents and Kits
Table 4. Global In-Vitro Cancer Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global In-Vitro Cancer Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global In-Vitro Cancer Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global In-Vitro Cancer Diagnostics Market Share by Regions (2016-2021)
Table 8. Global In-Vitro Cancer Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global In-Vitro Cancer Diagnostics Market Share by Regions (2022-2027)
Table 10. In-Vitro Cancer Diagnostics Market Trends
Table 11. In-Vitro Cancer Diagnostics Market Drivers
Table 12. In-Vitro Cancer Diagnostics Market Challenges
Table 13. In-Vitro Cancer Diagnostics Market Restraints
Table 14. Global In-Vitro Cancer Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global In-Vitro Cancer Diagnostics Market Share by Players (2016-2021)
Table 16. Global Top In-Vitro Cancer Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in In-Vitro Cancer Diagnostics as of 2020)
Table 17. Ranking of Global Top In-Vitro Cancer Diagnostics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by In-Vitro Cancer Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players In-Vitro Cancer Diagnostics Product Solution and Service
Table 21. Date of Enter into In-Vitro Cancer Diagnostics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global In-Vitro Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global In-Vitro Cancer Diagnostics Revenue Market Share by Type (2016-2021)
Table 25. Global In-Vitro Cancer Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global In-Vitro Cancer Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global In-Vitro Cancer Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global In-Vitro Cancer Diagnostics Revenue Market Share by Application (2016-2021)
Table 29. Global In-Vitro Cancer Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global In-Vitro Cancer Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America In-Vitro Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America In-Vitro Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America In-Vitro Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America In-Vitro Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America In-Vitro Cancer Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America In-Vitro Cancer Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe In-Vitro Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe In-Vitro Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe In-Vitro Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe In-Vitro Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe In-Vitro Cancer Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe In-Vitro Cancer Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific In-Vitro Cancer Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America In-Vitro Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America In-Vitro Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America In-Vitro Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America In-Vitro Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America In-Vitro Cancer Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America In-Vitro Cancer Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa In-Vitro Cancer Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 61. MDx Health Quest Diagnostics Company Details
Table 62. MDx Health Quest Diagnostics Business Overview
Table 63. MDx Health Quest Diagnostics In-Vitro Cancer Diagnostics Product
Table 64. MDx Health Quest Diagnostics Revenue in In-Vitro Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 65. MDx Health Quest Diagnostics Recent Development
Table 66. R-Biopharm AG Company Details
Table 67. R-Biopharm AG Business Overview
Table 68. R-Biopharm AG In-Vitro Cancer Diagnostics Product
Table 69. R-Biopharm AG Revenue in In-Vitro Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 70. R-Biopharm AG Recent Development
Table 71. Signature Diagnostics Company Details
Table 72. Signature Diagnostics Business Overview
Table 73. Signature Diagnostics In-Vitro Cancer Diagnostics Product
Table 74. Signature Diagnostics Revenue in In-Vitro Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 75. Signature Diagnostics Recent Development
Table 76. Siemens Healthcare Company Details
Table 77. Siemens Healthcare Business Overview
Table 78. Siemens Healthcare In-Vitro Cancer Diagnostics Product
Table 79. Siemens Healthcare Revenue in In-Vitro Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 80. Siemens Healthcare Recent Development
Table 81. Randox Laboratories Company Details
Table 82. Randox Laboratories Business Overview
Table 83. Randox Laboratories In-Vitro Cancer Diagnostics Product
Table 84. Randox Laboratories Revenue in In-Vitro Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 85. Randox Laboratories Recent Development
Table 86. Epigenomics AG Company Details
Table 87. Epigenomics AG Business Overview
Table 88. Epigenomics AG In-Vitro Cancer Diagnostics Product
Table 89. Epigenomics AG Revenue in In-Vitro Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 90. Epigenomics AG Recent Development
Table 91. Beckman Coulter Company Details
Table 92. Beckman Coulter Business Overview
Table 93. Beckman Coulter In-Vitro Cancer Diagnostics Product
Table 94. Beckman Coulter Revenue in In-Vitro Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 95. Beckman Coulter Recent Development
Table 96. Abbott Laboratories Company Details
Table 97. Abbott Laboratories Business Overview
Table 98. Abbott Laboratories Revenue in In-Vitro Cancer Diagnostics Business (2016-2021) & (US$ Million)
Table 99. Abbott Laboratories Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global In-Vitro Cancer Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. Instruments Features
Figure 3. Reagents and Kits Features
Figure 4. Global In-Vitro Cancer Diagnostics Market Share by Application: 2020 VS 2027
Figure 5. Laboratories Case Studies
Figure 6. Hospitals Case Studies
Figure 7. Others Case Studies
Figure 8. In-Vitro Cancer Diagnostics Report Years Considered
Figure 9. Global In-Vitro Cancer Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global In-Vitro Cancer Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global In-Vitro Cancer Diagnostics Market Share by Regions: 2020 VS 2027
Figure 12. Global In-Vitro Cancer Diagnostics Market Share by Regions (2022-2027)
Figure 13. Global In-Vitro Cancer Diagnostics Market Share by Players in 2020
Figure 14. Global Top In-Vitro Cancer Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in In-Vitro Cancer Diagnostics as of 2020
Figure 15. The Top 10 and 5 Players Market Share by In-Vitro Cancer Diagnostics Revenue in 2020
Figure 16. Global In-Vitro Cancer Diagnostics Revenue Market Share by Type (2016-2021)
Figure 17. Global In-Vitro Cancer Diagnostics Revenue Market Share by Type (2022-2027)
Figure 18. North America In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America In-Vitro Cancer Diagnostics Market Share by Type (2016-2027)
Figure 20. North America In-Vitro Cancer Diagnostics Market Share by Application (2016-2027)
Figure 21. North America In-Vitro Cancer Diagnostics Market Share by Country (2016-2027)
Figure 22. United States In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe In-Vitro Cancer Diagnostics Market Share by Type (2016-2027)
Figure 26. Europe In-Vitro Cancer Diagnostics Market Share by Application (2016-2027)
Figure 27. Europe In-Vitro Cancer Diagnostics Market Share by Country (2016-2027)
Figure 28. Germany In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific In-Vitro Cancer Diagnostics Market Share by Type (2016-2027)
Figure 36. Asia-Pacific In-Vitro Cancer Diagnostics Market Share by Application (2016-2027)
Figure 37. Asia-Pacific In-Vitro Cancer Diagnostics Market Share by Region (2016-2027)
Figure 38. China In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America In-Vitro Cancer Diagnostics Market Share by Type (2016-2027)
Figure 46. Latin America In-Vitro Cancer Diagnostics Market Share by Application (2016-2027)
Figure 47. Latin America In-Vitro Cancer Diagnostics Market Share by Country (2016-2027)
Figure 48. Mexico In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa In-Vitro Cancer Diagnostics Market Share by Type (2016-2027)
Figure 52. Middle East & Africa In-Vitro Cancer Diagnostics Market Share by Application (2016-2027)
Figure 53. Middle East & Africa In-Vitro Cancer Diagnostics Market Share by Country (2016-2027)
Figure 54. Turkey In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE In-Vitro Cancer Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. MDx Health Quest Diagnostics Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2016-2021)
Figure 58. R-Biopharm AG Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2016-2021)
Figure 59. Signature Diagnostics Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2016-2021)
Figure 60. Siemens Healthcare Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2016-2021)
Figure 61. Randox Laboratories Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2016-2021)
Figure 62. Epigenomics AG Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2016-2021)
Figure 63. Beckman Coulter Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2016-2021)
Figure 64. Abbott Laboratories Revenue Growth Rate in In-Vitro Cancer Diagnostics Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
世界のがん用体外診断 (IVD)市場 2021：企業別、地域別、種類・用途別 The In-Vitro Cancer Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade reg…- 世界の自己免疫疾患用体外診断用医薬品（IVD）・薬事未承認検査市場規模・現状・予測（2021年-2027年） In vitro diagnostics (IVD) are tests on bodily samples like blood, tissue or urine. IVDs are used to detect diseases, conditions, or infections.LDT for autoimmune diseases are tests specially developed in laboratory testing some autoimmune diseases. The market growth is attributed to rising occurren…
- 世界の体外診断市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global In-vitro Diagnostics Market The global In-vitro Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report m…
- 世界の体外診断市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global In-vitro Diagnostics Market The global In-vitro Diagnostics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report m…
- 世界の体外診断用医薬品（IVD）市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global In Vitro Diagnostics (IVD) Market The global In Vitro Diagnostics (IVD) market size is projected to reach US$ 120900 million by 2026, from US$ 76910 million in 2019, at a CAGR of 6.6% during 2021-2026. With industry-standard accuracy in analysis and high data int…